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Sarcoidosis is a multisystemic granulomatous disease of
unknown etiology. All body organs may be involved by
sarcoidosis; thus, magnetic resonance imaging (MRI) is an
important imaging modality. However, in the past, it was
impossible to perform magnetic resonance (MR) scanning
for extracardiac lesions in patients with cardiac sarcoidosis
requiring the implantation of traditional cardiac devices,
including pacemaker, implantable cardioverter-deﬁbrillator
(ICD), and cardiac resynchronization therapy deﬁbrillator
(CRT-D). Recently, MR-conditional devices have become
available; however, the experience of using MR-conditional
CRT-D is rare. We describe a patient with cardiac sarcoi-
dosis involving a cervical extradural lesion in whom efﬁcacy
of corticosteroid treatment for spinal lesion could be clearly
assessed by MRI after implanting of an MR-conditional
CRT-D.Case report
A 56-year-old woman was admitted to our hospital for
hemodynamically unstable ventricular tachycardia (VT)
treatment. She had no familial history of cardiovascular
disease or sudden cardiac death. The 12-lead electrocardio-
grams during sinus rhythm and VTs are shown in Figure 1.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).a ﬁrst-degree atrioventricular block and right bundle branch
block (Figure 1A). Two VTs were observed after admission
to our hospital (Figure 1B); VTs were suppressed by a
combination therapy of antiarrhythmic drugs (amiodarone
200 mg, carvedilol 5 mg, and mexiletine 300 mg). Her
transthoracic echocardiogram demonstrated a decreased left
ventricular ejection fraction (LVEF) of 42% and focal
thinning of the basal anterior septum and some focal intra-
cardiac mass in the ventricular septum and left ventricular
inferior wall. Cardiac MRI conﬁrmed myocardial edema
evidenced by increased signal intensity on T2-weighted
images, and late gadolinium enhancement was conﬁrmed
to match the intracardiac mass in the ventricular septum and
inferior wall (Figure 2). Fluorine-18-ﬂuorodeoxyglucose
(18F-FDG) positron emission tomography / computed tomo-
graphy revealed a strong 18F-FDG uptake in the myocardium
as focal or diffuse pattern and in the cervical spinal canal
(Figure 3A). Although the patient had no neurologic
symptoms, spinal gadolinium-enhanced MRI showed a focal
extradural lesion with high signal intensity at the C5-7 level
(Figure 3B). Sarcoidosis was strongly suspected by multi-
modality imaging. Ocular examination was normal. Serum
levels of angiotensin-converting enzyme, lysozyme, and
soluble interleukin-2 receptor were within normal limits.
The tuberculin reaction was negative. Angiography indicated
normal coronary arteries.
An endomyocardial biopsy was performed, and speci-
mens were obtained from the portion of the right side
of the ventricular septum. No obvious noncaseous granu-
loma with giant cells was observed; however, a small
inﬂammatory lesion that was formed by lymphocytes and
macrophages was found in a part of a specimen, and it
appeared to be a granulomatous lesion. There was no ﬁnding
of malignancy. On the basis of the above ﬁndings, the patient
was clinically diagnosed with cardiac sarcoidosis involving
cervical extradural lesion by the Japanese Ministry of
Health and Welfare criteria modiﬁed in 2006, including the
clinical/imaging pathway.1 She underwent implantation ofpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.11.003
KEY TEACHING POINTS
 Sarcoidosis is a granulomatous disease that may
involve multiple organs, including the heart and
the nervous system. Hence, magnetic resonance
imaging (MRI) is an important imaging modality
for diagnosing and evaluating disease
development.
 In the past, it was impossible to perform magnetic
resonance (MR) scanning for extracardiac lesions in
patients with cardiac sarcoidosis requiring the
implantation of traditional cardiac devices.
Recently, MR-conditional devices have become
available.
 We describe a patient with cardiac sarcoidosis
involving a cervical extradural lesion in whom the
efﬁcacy of corticosteroid treatment for spinal
lesion could be clearly assessed by MRI after
implanting an MR-conditional cardiac
resynchronization therapy deﬁbrillator.
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gression of conduction abnormality, and reduced LVEF
were observed. The device selected was an MR-
conditional CRT-D (Ilesto7HF-T DF-4Pro; BIOTRONIC,
Berlin, Germany) and leads (left ventricular lead, Corox
ProMRI OTW-L 85BP; right ventricular lead, Protego
ProMRI S65; atrial lead, Solia S53; BIOTRONIC, Berlin,
Germany).Figure 1 Twelve-lead electrocardiography (ECG). A: ECG during sinus rhyth
morphologies of VTs in the 12-lead ECG were observed; 1 VT exhibited a QRS c
exhibited a left bundle branch block–type morphology.After implantation of the CRT-D, prednisolone (30 mg)
was administered daily. 18F-FDG positron emission tomog-
raphy / computed tomography was performed to evaluate the
corticosteroid treatment after 5 months; abnormal uptake of
FDG at heart and spine completely disappeared (Figure 3C).
Spinal MRI was performed to evaluate the cervical extra-
dural lesion at the C5–7 level; however, it had completely
disappeared (Figure 3D). The patient had no cardiac events
such as recurrence of VT or heart failure during 10 months
after corticosteroid treatment, and her LVEF did not decrease
under all biventricular pacing.Discussion
The prognosis of sarcoidosis is affected by the presence of
myocardial lesions. However, diagnosis of cardiac sarcoi-
dosis is difﬁcult because endomyocardial biopsy is limited
by sampling and technical errors and has a low sensitivity.
The Heart Rhythm Society published a new criterion for the
diagnosis of cardiac sarcoidosis in 2014.2 Unfortunately, no
obvious noncaseous granuloma with giant cells was
observed in this case. Therefore, the patient was clinically
diagnosed with cardiac sarcoidosis using the Japanese
Ministry of Health and Welfare criteria.1 Although useful,
this criterion is limited by low diagnostic speciﬁcity. There-
fore, we tried to exclude other inﬂammatory and malignant
diseases before establishing the clinical diagnosis of cardiac
sarcoidosis.
Cardiac and neurologic sarcoidosis are rare; however, the
prevalence of subclinical cardiac and neurologic sarcoidosis
may be much higher. Baughman et al3 described that
approximately half of 736 sarcoidosis patients had multiplem on admission. B: ECG during ventricular tachycardias (VTs). Two QRS
omplex having a right bundle branch block–type morphology and the other
Figure 2 Cardiac magnetic resonance imaging (MRI). A: Cardiac MRI showing myocardial inﬂammation and edema. B: Late gadolinium enhancement was
conﬁrmed to match the intracardiac mass (red arrows).
Heart Rhythm Case Reports, Vol 2, No 1, January 201690organ involvement. Therefore, the patients with cardiac
sarcoidosis involving neurologic lesions may be more
common than documented. Additionally, sarcoidosis is a
progressive disease. If the sarcoidosis patients have single-
area involvement at the time of ﬁrst diagnosis, multiple organFigure 3 Fluorine-18-ﬂuorodeoxyglucose (18F-FDG) positron emission tomog
imaging (MRI) obtained before and after corticosteroid treatment and the implantati
in each ﬁgure shows sagittal view, and the right panel shows transaxial view). A:
canal before treatment (white arrows). B: Gadolinium-enhanced MRI showed
(red arrow). C: Follow-up 18F-FDG PET/CT showed a disappearance of abnor
treatment. D: The follow-up MRI 5 months after treatment showing a further dec
implantation.involvement may develop during follow-up. Thus, MRI
must be an essential imaging modality in patients with
cardiac sarcoidosis because extracardiac lesions, particularly
neurologic lesions such as spinal sarcoidosis, should be
evaluated by MRI.4 Recently, MR-conditional devices haveraphy (PET) / computed tomography (CT) and spinal magnetic resonance
on of a cardiac resynchronization therapy deﬁbrillator (CRT-D) (the left panel
Abnormal uptake of 18F-FDG was registered in the heart and cervical spinal
a cervical extradural lesion with high signal intensity at the C5 -7 level
mal 18F-FDG uptake in the heart and cervical spinal canal 5 months after
line of the epidural lesion. Very clear images were obtained despite CRT-D
91Kawakami et al Use of MR-Conditional CRT-D in Cardiac Sarcoidosisbecome available. However, there is no report that MRI was
performed for extracardiac lesions after implantation of
MR-conditional devices. To the best of our knowledge, this
is the ﬁrst report on detailed evaluation and assessment of
corticosteroid treatment for a cervical extradural lesion
performed in a patient with cardiac sarcoidosis and a CRT-
D implant.
In the present case, the patient had hemodynamically
unstable VTs; thus ICD was essential. We implanted a CRT-
D, not an ICD, because progressive conduction abnormal-
ities, including a ﬁrst-degree atrioventricular block, were
observed and LVEF was moderately decreased. Some
studies described that high percentages of right ventricular
pacing may promote left ventricular systolic dysfunction.5,6
Curtis et al7 proposed that biventricular pacing was superior
to right ventricular pacing in patients with atrioventricular
block. There is a possibility of atrioventricular block
progressing along with the progress of disease. Currently,
atrioventricular block is progressive despite corticosteroid
treatment, and the patient required biventricular pacingduring follow-up; however, her LVEF has not reduced,
and she has not developed any cardiac events.
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